Safety and efficacy of tixagevimab/cilgavimab for pre-exposure prophylaxis in kidney transplant recipients: a multicenter retrospective cohort study
HIGHLIGHTS What: The study showed that tixagevimab/cilgavimab 150/150 mg is effective and safe in preventing infection and severe disease when […]